Cannabis

Department of Health written question – answered at on 22 November 2016.

Alert me about debates like this

Photo of Crispin Blunt Crispin Blunt Chair, Foreign Affairs Committee, Chair, Foreign Affairs Committee

To ask the Secretary of State for Health, whether (a) his Department and (b) the Medicine and Healthcare Products Regulatory Agency has reviewed the latest evidence, including evidence on different regulatory approaches in other jurisdictions, for the use of medical cannabis.

Photo of Nicola Blackwood Nicola Blackwood The Parliamentary Under-Secretary of State for Health

The Medicines and Healthcare products Regulatory Agency (MHRA) reviews evidence submitted by a company seeking a marketing authorisation for a medicinal product in the United Kingdom. One product containing extracts of cannabis, Sativex, has been licensed as a medicinal product by the MHRA. However, no such application has been received in respect of herbal cannabis, and therefore the MHRA has undertaken no review of the evidence for its medicinal use. Outwith the MHRA licensing process, the Department has not conducted or commissioned a review of herbal cannabis or its regulation in other jurisdictions.

Does this answer the above question?

Yes1 person thinks so

No4 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.